Nicole Vitullo

Partner at Domain Associates LLC

Nicole Vitullo

Nicole Vitullo

Partner at Domain Associates LLC

Overview
RelSci Relationships

1475

Number of Boards

16

Birthday

1958

Age

61

Relationships
RelSci Relationships are individuals Nicole Vitullo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Domain Associates LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Esperion Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Domain Associates LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Managing Director at BioScience Managers Pty Ltd

Relationship likelihood: Strong

Co-Founder at Esperion Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer & Non-Executive Director at Avita Medical Ltd.

Relationship likelihood: Strong

Co-Founder & Chief Financial Officer at PocketList

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Paths to Nicole Vitullo
Potential Connections via
Relationship Science
You
Nicole Vitullo
Partner at Domain Associates LLC
Education
MBA
Class of 1990

At Simon Business School, we offer an education that will attract students who value our analytic bias.

BA

The University of Rochester is a private, nonsectarian, research university in Rochester, New York, United States. The university grants undergraduate and graduate degrees, including doctoral and professional degrees. The university has six schools and various interdisciplinary programs. The University of Rochester is noted for its Eastman School of Music. The university is also home to the Institute of Optics, founded in 1929, the first educational program in the US devoted exclusively to optics. Rochester's Laboratory for Laser Energetics is home to the second most energetic fusion laser in the world.

Career History
Director
2017 - Current

Rosetta is an active manager investing in early and mid-stage growth companies in biotechnology-related sectors. The firm makes both direct equity investments and secondary investments. They also invest in acquisition financing and spin-off transactions.

Partner
1999 - Current

Domain Associates invests exclusively in emerging life sciences companies. The firm focuses on pharmaceuticals, specialty pharmaceuticals and medical devices and they are also interested in biomaterials, bioinstrumentation and diagnostics. They prefer to be part of the first institutional financing round of a company. They look for companies with outstanding technology addressing unmet needs in very large markets led by exceptional management. Once invested, Domain takes an active role in guiding the growth of the company. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies that are implementing a new corporate strategy.

Professional
Current

BMPL invests in mid stage companies located in Europe, the USA and Australia. The firm target companies operating in the fields of healthcare and life sciences companies.

Boards & Committees
Director
1998 - 2005

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. At Onyx, we are grounded in three leadership hallmarks that guide how we manage our business and build value for patients and shareholders: innovation, patient-centeredness and stewardship.

Director
Prior

Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD.

Political Donations
$2,142
2011
$2,000
2010
$2,000
2009
Transactions
Details Hidden

Domain Partners VIII LP raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York-Northern New Jersey-Long Island, NY-NJ-PA Metropolitan Statistical Area
5th Annual Women's Alternative Investment Summit

The 5th Annual Women's Alternative Investment Summit is a conference to enhance networking, fundraising, and deal-making opportunities for senior-level women across the broad spectrum of alternative investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nicole Vitullo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nicole Vitullo's profile does not indicate a business or promotional relationship of any kind between RelSci and Nicole Vitullo.